# 2-Hydroxybenzylamine (2-HOBA) Study in Early Alzheimer's Patients

> clinical trial · VERIFIED · 2026-08-24

Status: NOT_YET_RECRUITING · Sponsor: MTI Biotech Inc · Condition: Alzheimer Disease

- Company: MTI Biotech Inc
- Sector: therapeutics
- Primary source: https://clinicaltrials.gov/study/NCT06432166

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.